IVY Pharma specializes in licensing, developing and distributing therapeutic and aesthetic proteins globally. Our pipeline covers biosimilars, vaccines and novel biomolecules for aesthetic and various chronic diseases. Through collaborations with leading laboratories under an licensing, acquisition and partnership program, IVY Pharma is building a portfolio of additional pipelines for further development and commercialization. Several promising anti-cancer biotherapeutics with enhanced efficacy and reduced toxicities are in the pipeline. IVY Pharma has a highly experienced leadership team that brings extensive experience in business development, financing and sales and marketing. We have a focused business strategy comprised of three key components.
| Website | http://ivypharma.com |
| Revenue | $5 million |
| Employees | 4 (0 on RocketReach) |
| Address | 140 E Ridgewood Ave Ste 415, Paramus, New Jersey 07652, US |
| Phone | +1 201-885-3708 |
| Industry | Manufacturing General, Manufacturing |
| Keywords | Biosimilars, Therapeutic Proteins, Protein Therapeutics, Biopharmaceutical, Vaccines, Biomolecules, Biotechnology, Drug Development, Chronic Disease Treatment, Drug Pipeline, Life Sciences, Drug Distribution, Pharmaceutical Licensing, Aesthetic Medicine, Protein Manufacturing, Global Pharma, Clinical Development, Pharmaceutical Collaborations |
| Competitors | Johnson & Johnson, Roche, Novartis, AbbVie, Merck & Co., Inc., Pfizer, Sanofi, GSK, Bristol Myers Squibb, Amgen +39 more (view full list) |
| SIC | SIC Code 28 Companies, SIC Code 283 Companies |
| NAICS | NAICS Code 32541 Companies, NAICS Code 325 Companies, NAICS Code 3254 Companies, NAICS Code 32 Companies |
Looking for a particular IVY Pharma employee's phone or email?
IVY Pharma Questions
The IVY Pharma annual revenue was $5 million in 2026.
IVY Pharma is based in Paramus, New Jersey.
The NAICS codes for IVY Pharma are [32541, 325, 3254, 32].
The SIC codes for IVY Pharma are [28, 283].
Related Companies
